197 related articles for article (PubMed ID: 36028388)
1. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
Alreshq R; Cozzolino M; Lilleness B; Pipilas A; Mendelson L; Joshi T; Muralidhar V; Guardino E; Berk JL; Siddiqi OK; Gopal DM; Sanchorawala V; Ruberg FL
Am J Cardiol; 2022 Oct; 181():105-112. PubMed ID: 36028388
[TBL] [Abstract][Full Text] [Related]
2. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
3. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
6. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
[TBL] [Abstract][Full Text] [Related]
7. Inter-observer reproducibility and intra-observer repeatability in
Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
[TBL] [Abstract][Full Text] [Related]
8. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
9. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV
Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
[TBL] [Abstract][Full Text] [Related]
12.
Wlodarski R; Seibert K; Issa NP; O'Brien-Penney B; Soliven B; Sarswat N; Appelbaum D; Rezania K
Muscle Nerve; 2023 Feb; 67(2):111-116. PubMed ID: 36222831
[TBL] [Abstract][Full Text] [Related]
13. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
Takahashi K; Sasaki D; Yamashita M; Sakaue T; Enomoto D; Morioka H; Uemura S; Okura T; Ikeda S; Kono T; Hiratsuka Y; Saijo A; Yamamura N; Kitazawa S; Yamashita T; Ueda M
J Nucl Cardiol; 2022 Dec; 29(6):3126-3136. PubMed ID: 34964085
[TBL] [Abstract][Full Text] [Related]
14. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
[TBL] [Abstract][Full Text] [Related]
16. Serial scanning with technetium pyrophosphate (
Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
[TBL] [Abstract][Full Text] [Related]
17. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
Davies DR; Redfield MM; Scott CG; Minamisawa M; Grogan M; Dispenzieri A; Chareonthaitawee P; Shah AM; Shah SJ; Wehbe RM; Solomon SD; Reddy YNV; Borlaug BA; AbouEzzeddine OF
JAMA Cardiol; 2022 Oct; 7(10):1036-1044. PubMed ID: 36069809
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.
Chan N; Einstein AJ; Griffin JM; Rosenblum H; Teruya S; Cuomo M; De Los Santos J; DeLuca A; Johnson LL; Kinkhabwala MP; Leb JS; Mintz A; Fine D; Helmke S; Muralidhar V; Pandey S; Sabogal N; Saith SE; Winburn M; Smiley D; Miller EJ; Ruberg FL; Maurer MS
J Nucl Cardiol; 2023 Dec; 30(6):2531-2539. PubMed ID: 37311914
[TBL] [Abstract][Full Text] [Related]
19. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
